Valeritas Holdings Inc. said it received a letter from Nasdaq stating the company was in compliance with listing rules.

The Nasdaq decision was based on the medical technology company's Form 10-Q disclosure for the period ended March 30, Valeritas said in an SEC filing.

The exchange had sent a notice to the New Jersey-based company in March saying it failed to comply with the requirements of minimum stockholders' equity at $2.5 million, market value of listed securities at $35 million and net income from continuing operations at $500,000.